Pharmaconex is part of the Informa Markets Division of Informa PLC


Featured News

Egypt Outpacing Middle East and Africa’s Top Markets

Four years after Egypt enacted a new universal health law, the country’s pharmaceutical market has consolidated itself as the fastest growing in the Middle East and Africa, far outpacing Saudi Arabia, South Africa, the UAE and Algeria. With USD 6.3 billion in value, Egyptian pharma is about to double its size from 2017. 


Source: Pharma Boardroom

U.S. adds 2.5 million Bavarian Nordic monkeypox vaccine doses, expects more in July

July 15 (Reuters) - The U.S. government has ordered an additional 2.5 million doses of Bavarian Nordic's (BAVA.CO) vaccine for use against monkeypox and expects more later this month to fight an outbreak of the viral disease. 


Source: Reuters


What our Exhibitors have said about Pharmaconex 2022!

Harsha V Nandepu, Chief Operating Officer 


Yara Al- Almouti, CEO
Agon Consulting
Vita Starastenko, Market Development Manager